Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-20-052337

Director bought 950,000 shares at $18.00 ($17,100,000)

  • Director acquired 6,114,330 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Thompson Peter A. Director 2020-09-25 Purchase +475,000 $18.00 $8,550,000 475,000 I: show line 1 in the form
Thompson Peter A. Director 2020-09-29 Conversion +4,025,076 4,500,076 I: show line 2 in the form
Thompson Peter A. Director 2020-09-29 Conversion +1,076,891 5,576,967 I: show line 3 in the form
Thompson Peter A. Director 2020-09-29 Conversion +518,191 6,095,158 I: show line 4 in the form
Thompson Peter A. Director 2020-09-29 Conversion +380,133 6,475,291 I: show line 5 in the form
Thompson Peter A. Director 2020-09-29 Conversion +114,039 114,039 I: show line 6 in the form
Thompson Peter A. Director 2020-09-25 Purchase +475,000 $18.00 $8,550,000 475,000 I: show line 7 in the form
Open-market purchases · 950,000 sh · avg $18.00 · $17,100,000

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Thompson Peter A. Director 2020-09-29 Conversion · Series A Preferred Stock −4,025,076 0 I: show line 8 in the form
Thompson Peter A. Director 2020-09-29 Conversion · Series B Preferred Stock −1,076,891 0 I: show line 9 in the form
Thompson Peter A. Director 2020-09-29 Conversion · Series C Preferred Stock −518,191 0 I: show line 10 in the form
Thompson Peter A. Director 2020-09-29 Conversion · Series D Preferred Stock −380,133 0 I: show line 11 in the form
Thompson Peter A. Director 2020-09-29 Conversion · Series D Preferred Stock −114,039 0 I: show line 12 in the form
Loading xslF345X03/doc4.xml…